Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples